$1.69
▲ +1.5% Today
as of Oct 23, 09:51 ET
Last 30 days
Recent Press Releases & News
Natera Partners With TransCode to Advance Colorectal Cancer Trial
TransCode Therapeutics to Present Phase 1a Clinical Trial Data for TTX-MC138 at ESMO Congress 2026
Natera, TransCode Collaborate to Improve Enrollment for Colorectal Cancer Trial
RNAZ earnings at a glance
Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±1.4% on average; after the most recent report on May 15, 2026 it moved -2.8%. The share price of $1.69 sits near its 52-week low.
Overview
52-week range
$1.52
$14
1% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-1.4%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-7.17 | — | — | — | — | financials |
| Fri May 15, 2026 | Mar/2026 | $-21.28 | — | — | -3,447% | -2.8% | earnings |
| Fri Nov 14, 2025 | Sep/2025 | $-5.49 | — | — | — | — | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $-4.94 | — | — | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.60 | — | — | — | 0.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-146.06 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-680.23 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-21.35 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-48.44 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-142.38 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-259.07 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-7M | $-18M | — | $-5M | $-4M | $-3M | — | $-2M |
| Net income | $-7M | $-18M | — | $-5M | $-4M | $-12M | — | $-2M |
| EPS (diluted) | $-7.17 | $-21.28 | — | $-5.82 | $-5.13 | $-70.16 | — | $-146.06 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $8M | $13M | $18M | $3M | $7M | $12M | $6M | $2M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $11M | $17M | $22M | $5M | $8M | $13M | $7M | $4M |
| Total assets | $151M | $157M | $162M | $5M | $8M | $13M | $7M | $4M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $13M | $13M | $11M | $4M | $2M | $3M | $9M | $2M |
| Total equity | $-28M | $1M | $10M | $1M | $6M | $10M | $-2M | $2M |
Implied volatility — last 90 days
No IV snapshots yet for RNAZ.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
RNAZ earnings FAQ
How does RNAZ stock usually react to earnings?
Across the last 2 reports the average next-day move was ±1.4%, up 0 times and down 2 times.